Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Proceedings of the 8th Global Arthritis Research Network (GARN) Meeting and 1st Bio-Rheumatology International Congress (BRIC)

Poster presentation

Osteoprotegerin induction in response to microbial infection

Yasunari Takada* and Koichi Matsuo

  • * Corresponding author: Yasunari Takada

Author Affiliations

Laboratory of Cell and Tissue Biology, Keio Univ. School of Medicine, Tokyo 160-8582 Japan

For all author emails, please log on.

Arthritis Research & Therapy 2012, 14(Suppl 1):P67  doi:10.1186/ar3668


The electronic version of this article is the complete one and can be found online at: http://arthritis-research.com/content/14/S1/P67


Published:9 February 2012

© 2012 Takada and Matsuo; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Poster presentation

Osteoprotegeirn (OPG) is an endogenous decoy receptor for RANKL, which is a cytokine essential for osteoclast differentiation. Lipopolysaccharide (LPS) is known to induce osteoclast formation when injected onto calvaria in mice. Unexpectedly, we observed that mice injected with LPS up-regulate OPG and down-regulate RANKL levels in peripheral blood.

In the present study, we examined whether OPG is induced by microbial infection of various kinds, and the sites and significance of OPG production in infected mice. Wild-type mice infected withSalmonella, Staphylococcus, Mycobacteriaor influenza virus showed increase in OPG levels in peripheral blood. We also found that the levels of OPG in serum of human patients infected with M. tuberculosis and M. avium were significantly increased. Moreover, injection of mice with LPS induced OPG production specifically in lymph nodes, especially in high endothelial venule (HEV)cells, but not in other organs. OPG production was suppressed in c-Fos-deficient mice and enhanced in Fra-1 transgenic mice, indicating that OPG production is regulated by AP-1 transcription factors. Loss of OPG in mice did not affect either their survival or Salmonella proliferation in spleen and liver after infection with virulent strains of Salmonella. Interestingly, however, when wild-type mice were infected with an avirulent Salmonella strain, which can induce OPG, osteoclast development was suppressed and bone mineral density was increased. These data reveal for the first time that lymph nodes protect bones from infection-induced bone loss through OPG production.